Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: D-serine Augmentation of Neuroplasticity [Phase 1, Phase 2]
Phase 1/2 trial updates on D-serine augmentation to enhance neuroplasticity in schizophrenia and schizoaffective disorder; study completed w…
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Effects of Galantamine on Cognition [Phase 2]
Phase 2 trial investigating the effects of galantamine on cognition in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Research Into Antipsychotic Discontinuation and Reduction Trial [Phase 4]
Phase 4 trial updating research on discontinuation and reduction strategies for antipsychotics in schizophrenia-spectrum disorders.
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1 [Phase 2]
Phase 2 trial of targeted pharmacological and behavioral treatments for tobacco dependence in schizophrenia has been terminated with results…
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia [NA]
A terminated clinical trial investigating the effects of transdermal nicotine on response inhibition to emotional cues in schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia [Phase 2]
Phase 2 safety and biomarker study of RL-007 in subjects with schizophrenia completed.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder. [Phase 2]
Phase 2 trial evaluating sodium benzoate and/or N-acetylcysteine added to treatment as usual in early schizophrenia spectrum disorders has c…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness [NA]
Clinical trial investigating integrated smoking cessation treatment for individuals with serious mental illness completed with results poste…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia [Phase 4]
Phase 4 trial comparing oral risperidone to injectable paliperidone palmitate for first-episode schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months [Phase 2]
Phase 2 trial in schizophrenia evaluating tolerability and efficacy of BI 409306 over 6 months; the study was terminated and results have be…
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia [Phase 3]
A Phase 3 trial evaluating cariprazine in a dose-reduction strategy for relapse prevention in schizophrenia was terminated; results were pos…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Telmisartan Pilot Study on Treatment Resistant Schizophrenia [Phase 2]
Phase 2 pilot study on telmisartan for treatment-resistant schizophrenia was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension [Phase 3]
Open-label extension of a Phase 3 trial evaluating risperidone ISM in acute schizophrenia; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) [Phase 3]
Phase 3 trial evaluating efficacy and safety of asenapine using an active control in adults with schizophrenia or schizoaffective disorder; …
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) [Phase 3]
Phase 3 long-term efficacy and safety trial evaluating asenapine with olanzapine as a positive control in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients [Phase 4]
Phase 4 trial updating a comparison between berberine and metformin for metabolic syndrome in schizophrenia patients.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Targeting Auditory Hallucinations With Alternating Current Stimulation [NA]
A completed clinical trial investigating alternating current stimulation for auditory hallucinations in schizophrenia/schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia [Phase 2]
An extension Phase 2 study evaluating the safety and tolerability of SEP-363856 in adults with schizophrenia has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia [Phase 3]
Phase 3 trial assessing efficacy and safety of Risperidone in Situ Microparticle (ISM) for acute schizophrenia has completed with results po…
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Improving Accessibility and Personalization of CR for Schizophrenia [NA]
A completed clinical trial exploring accessibility and personalization of cognitive rehabilitation for schizophrenia and schizoaffective dis…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis [Phase 1, Phase 2]
A placebo-controlled study of IV ceftriaxone for refractory psychosis was terminated; results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia [Phase 4]
Phase 4 clinical trial assessing computerized cognitive remediation therapy for schizophrenia completed; results not provided in snippet.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of WID-RGC20 (Cariprazine) in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics [Phase 4]
Phase 4 trial update evaluating maintenance of efficacy and safety after switching to a long-acting injectable aripiprazole from oral atypic…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: A Study of Paliperidone Palmitate 6-Month Formulation [Phase 3]
Phase 3 trial of paliperidone palmitate 6-month formulation for schizophrenia has been completed. Results have been posted.